ProMIS Neurosciences, Inc. (PMN)
3.14
-0.07
(-2.18%)
USD |
NASDAQ |
Nov 18, 14:59
ProMIS Neurosciences Price : 3.14 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.12 | 3.39 | 3.10 | 3.21 | 145570.0 |
| Nov 16, 2026 | 3.28 | 3.485 | 3.146 | 3.31 | 130688.0 |
| Nov 13, 2026 | 3.79 | 3.79 | 2.98 | 3.29 | 156544.0 |
| Nov 12, 2026 | 3.76 | 3.84 | 3.40 | 3.48 | 128754.0 |
| Nov 11, 2026 | 4.09 | 4.219 | 3.69 | 3.76 | 111864.0 |
| Nov 10, 2026 | 3.99 | 4.30 | 3.86 | 3.98 | 212692.0 |
| Nov 09, 2026 | 4.24 | 4.30 | 4.00 | 4.05 | 159029.0 |
| Nov 06, 2026 | 3.76 | 4.33 | 3.70 | 4.16 | 375158.0 |
| Nov 05, 2026 | 3.55 | 3.76 | 3.40 | 3.65 | 272096.0 |
| Nov 04, 2026 | 3.41 | 3.54 | 3.02 | 3.52 | 517023.0 |
| Nov 03, 2026 | 3.29 | 3.62 | 3.28 | 3.41 | 995253.0 |
| Nov 02, 2026 | 3.59 | 4.50 | 2.780 | 3.00 | 3.536M |
| Oct 30, 2026 | 8.41 | 8.530 | 3.21 | 3.31 | 1.640M |
| Oct 29, 2026 | 10.87 | 11.38 | 10.35 | 11.08 | 132847.0 |
| Oct 28, 2026 | 9.58 | 11.76 | 9.58 | 11.07 | 50647.00 |
| Oct 27, 2026 | 8.36 | 10.28 | 8.36 | 9.68 | 53060.00 |
| Oct 26, 2026 | 8.46 | 8.87 | 7.743 | 8.06 | 21999.00 |
| Oct 23, 2026 | 8.65 | 8.80 | 8.24 | 8.34 | 10442.00 |
| Oct 22, 2026 | 9.06 | 9.31 | 8.88 | 8.98 | 6440.00 |
| Oct 21, 2026 | 8.40 | 9.13 | 8.18 | 9.13 | 7486.00 |
| Oct 20, 2026 | 8.34 | 8.65 | 8.06 | 8.09 | 30254.00 |
| Oct 19, 2026 | 8.36 | 8.385 | 8.06 | 8.23 | 11343.00 |
| Oct 16, 2026 | 8.89 | 9.64 | 7.935 | 8.15 | 20418.00 |
| Oct 15, 2026 | 8.29 | 8.87 | 8.00 | 8.70 | 33544.00 |
| Oct 14, 2026 | 8.41 | 8.81 | 8.16 | 8.285 | 23376.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Edesa Biotech, Inc. | 2.02 |
| Oncolytics Biotech, Inc. | 0.397 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 14.64 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| Price to Book Value | 0.6744 |
| Earnings Yield | -267.4% |
| Market Cap | 28.16M |